ArticleScience advances2024

Neoadjuvant radioimmunotherapy in pancreatic cancer enhances effector T cell infiltration and shortens their distances to tumor cells.

Junke Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.